Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The case for low-level BACE1 inhibition for the prevention of Alzheimer disease
Eric McDade, Iryna Voytyuk, Paul Aisen, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 703-714
Closed Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Mouse Models of Alzheimer’s Disease
Miyabishara Yokoyama, Honoka Kobayashi, Lisa Tatsumi, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 133
Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers
Todd E. Golde
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 209-227
Open Access | Times Cited: 84
Detection and treatment of Alzheimer’s disease in its preclinical stage
Michael S. Rafii, Paul Aisen
Nature Aging (2023) Vol. 3, Iss. 5, pp. 520-531
Closed Access | Times Cited: 59
Advances in Alzheimer’s disease’s pharmacological treatment
Carlos Elias Conti Filho, Lairane Bridi Loss, Clairton Marcolongo-Pereira, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 50
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer’s disease
Marko Jörg, Johanna E. Plehn, Marco Kristen, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1427-1439
Open Access | Times Cited: 21
ADME profiling, molecular docking, DFT, and MEP analysis reveal cissamaline, cissamanine, and cissamdine from Cissampelos capensis L.f. as potential anti-Alzheimer's agents
Maram B. Alhawarri, Mohammad G. Al‐Thiabat, Amit Dubey, et al.
RSC Advances (2024) Vol. 14, Iss. 14, pp. 9878-9891
Open Access | Times Cited: 21
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 21
BACE1: More than just a β‐secretase
Hannah A. Taylor, Lena Przemyłska, Eva M. Clavane, et al.
Obesity Reviews (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 65
Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
Madhu Ramesh, Thimmaiah Govindaraju
Chemical Science (2022) Vol. 13, Iss. 46, pp. 13657-13689
Open Access | Times Cited: 52
Conquering Alzheimer’s: a look at the therapies of the future
Alison Abbott
Nature (2023) Vol. 616, Iss. 7955, pp. 26-28
Closed Access | Times Cited: 28
The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Stephan A. Müller, Merav D. Shmueli, Xiao Feng, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Inhibition of ferroptosis through regulating neuronal calcium homeostasis: An emerging therapeutic target for Alzheimer’s disease
Yiran Sun, Chenchen Yan, Libo He, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101899-101899
Closed Access | Times Cited: 26
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 14
In-situ Nanozyme Catalytic Amplification Coupled with a Universal Antibody Orientation Strategy based Electrochemical Immunosensor for AD-Related Biomarker
Xiyu Chen, Yang Huang, Shuo Yang, et al.
Biosensors and Bioelectronics (2024) Vol. 266, pp. 116738-116738
Closed Access | Times Cited: 11
Di Huang Yi Zhi Fang improves cognitive function in APP/PS1 mice by inducing neuronal mitochondrial autophagy through the PINK1-parkin pathway
Limin Zhang, Hong‐Mei An, Rong-Rong Zhen, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Stefan F. Lichtenthaler, Sarah K. Tschirner, Harald Steiner
Current Opinion in Neurobiology (2021) Vol. 72, pp. 101-110
Closed Access | Times Cited: 44
The emerging role of furin in neurodegenerative and neuropsychiatric diseases
Yi Zhang, Xiaoqin Gao, Xue Bai, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 36
AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
Marika Marino, Lujia Zhou, Melvin Y. Rincón, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 32
Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules
Nassima Oumata, Kui Lu, Yuou Teng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114578-114578
Closed Access | Times Cited: 29
Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats
Xiying Guo, Min Lei, Jiangyan Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Nanomodulators That Target Alzheimer’s Disease: A Review
Nibedita Pradhan, Nihar Ranjan Jana
ACS Applied Nano Materials (2024) Vol. 7, Iss. 4, pp. 3515-3545
Closed Access | Times Cited: 7
Thioamides in medicinal chemistry and as small molecule therapeutic agents
G. Huang, Tomasz Cierpicki, Jolanta Grembecka
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116732-116732
Closed Access | Times Cited: 6
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
Johannes Levin, Jonathan Vöglein, Yakeel T. Quiroz, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 12, pp. 2687-2698
Open Access | Times Cited: 26
Printed Electrochemical Strip for the Detection of miRNA-29a: A Possible Biomarker Related to Alzheimer’s Disease
Antonella Miglione, Ada Raucci, Jussara Amato, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 45, pp. 15558-15563
Open Access | Times Cited: 24
BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides
John Zhou, Neeraj Singh, James Galske, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top